IDXX logo

IDEXX Laboratories, Inc. Stock Price

NasdaqGS:IDXX Community·US$52.3b Market Cap
  • 3 Narratives written by author
  • 1 Comments on narratives written by author
  • 61 Fair Values set on narratives written by author

IDXX Share Price Performance

US$660.71
219.68 (49.81%)
US$750.23
Fair Value
US$660.71
219.68 (49.81%)
11.9% undervalued intrinsic discount
US$750.23
Fair Value
Price US$660.71
AnalystConsensusTarget US$750.23
AnalystLowTarget US$579.18
AnalystHighTarget US$850.00

IDXX Community Narratives

AnalystConsensusTarget·
Fair Value US$750.23 11.9% undervalued intrinsic discount

IDXX: Expanding Installed Base Will Drive Accelerating Business Momentum Ahead

1users have liked this narrative
0users have commented on this narrative
24users have followed this narrative
AnalystLowTarget·
Fair Value US$579.18 14.1% overvalued intrinsic discount

Declining Pet Ownership And Rising Compliance Costs Will Erode Margins

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystHighTarget·
Fair Value US$850 22.3% undervalued intrinsic discount

Global Pet Ownership And AI Diagnostics Will Expand Market Opportunities

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
US$579.18
14.1% overvalued intrinsic discount
Revenue
8.8% p.a.
Profit Margin
25.78%
Future PE
39.22x
Price in 2029
US$718.1

Trending Discussion

Updated Narratives

IDXX logo

IDXX: New Diagnostics Pipeline And Margin Outlook Will Support Future Shareholder Value

Fair Value: US$750.23 11.9% undervalued intrinsic discount
24 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
IDXX logo

IDXX: Recurring Diagnostics And Cancer Testing Pipeline Will Support Long Term Earnings Power

Fair Value: US$850 22.3% undervalued intrinsic discount
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
IDXX logo

IDXX: Rich P/E Leaves Little Room For Cancer Diagnostics Execution Missteps

Fair Value: US$579.18 14.1% overvalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Outstanding track record with excellent balance sheet.

1 Risk
2 Rewards

IDEXX Laboratories, Inc. Key Details

US$4.3b

Revenue

US$1.6b

Cost of Revenue

US$2.7b

Gross Profit

US$1.6b

Other Expenses

US$1.1b

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
13.31
61.80%
24.62%
52.8%
View Full Analysis

About IDXX

Founded
1983
Employees
11000
CEO
Jonathan Mazelsky
WebsiteView website
www.idexx.com

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Recent IDXX News & Updates

Recent updates

No updates